Patents by Inventor Soren Christensen

Soren Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050049205
    Abstract: Glycosides of diacylglycerol, e.g. 3-?-D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO), which was isolated from extracts of rose-hips by activity guided fractionation, can be used as an oral anti-inflammatory agent for the treatment of inflammatory diseases such as arthritis and osteoarthrosis.
    Type: Application
    Filed: October 13, 2004
    Publication date: March 3, 2005
    Inventors: Erik Larsen, Arsalan Kharazmi, Soren Christensen, Lars Christensen, Kirsten Brandt
  • Publication number: 20050009068
    Abstract: The inventors have isolated lysophospholipases from Aspergillus (A. niger and A. oryzae) having molecular masses of about 68 kDa and amino acid sequences of 600-604 amino acid residues. The novel lysophospholipases have only a limited homology to known amino acid sequences. The inventors also isolated genes encoding the novel enzymes and cloned them into E. coli strains.
    Type: Application
    Filed: May 19, 2004
    Publication date: January 13, 2005
    Applicant: Novozymes A/S
    Inventors: Hiroaki Udagawa, Torben Frandsen, Tom Nielsen, Markus Kauppinen, Soren Christensen
  • Patent number: 6759225
    Abstract: The inventors have isolated lysophospholipases from Aspergillus (A. niger and A. oryzae) having molecular masses of about 68 kDa and amino acid sequences of 600-604 amino acid residues. The novel lysophospholipases have only a limited homology to known amino acid sequences. The inventors also isolated genes encoding the novel enzymes and cloned them into E. coli strains.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: July 6, 2004
    Assignee: Novozymes A/S
    Inventors: Hiroaki Udagawa, Torben Peter Frandsen, Tom Anton Busk Nielsen, Markus Sakari Kauppinen, Soren Christensen
  • Publication number: 20040122216
    Abstract: Methods and compositions are provided for protecting or enhancing a responsive cell, tissue, organ or body part function or viability in vivo, in situ or ex vivo in mammals, including human beings, by systemic or local administration of an erythropoietin receptor activity modulator, such as an recombinant tissue protective cytokine.
    Type: Application
    Filed: July 1, 2003
    Publication date: June 24, 2004
    Inventors: Jacob Nielsen, Jan Torleif Pedersen, Jens Gerwien, Katrine Bay, Lars Ostergaard Pedersen, Marcel Leist, Marie Aavang Geist, Pekka Kallunki, Soren Christensen, Thomas Sager, Michael Brines, Anthony Cerami, Carla Cerami
  • Publication number: 20030199048
    Abstract: An esterase isolated from Aspergillus oryzae is capable of stereoselective hydrolysis of chiral esters and also has arylesterase activity (EC 3.1.1.2) and feruloyl esterase activity (EC 3.1.1.73). The esterase has only a limited homology to known amino acid sequences.
    Type: Application
    Filed: February 5, 2003
    Publication date: October 23, 2003
    Inventors: Peter Rahbek Ostergaard, Carsten M Hjort, Heinz-Josef Deussen, Magali Zundel, Soren Ebdrup, Soren Christensen, Shamkant Anant Patkar
  • Publication number: 20030180416
    Abstract: The properties of dough or bread can be improved by the addition of a carbohydrate oxidase which can oxidize the reducing end of an oligosaccharide more efficiently than the corresponding monosaccharide, e.g., preferentially oxidizing maltodextrins or cellodextrins over glucose.
    Type: Application
    Filed: December 6, 2002
    Publication date: September 25, 2003
    Applicant: Novozymes A/S
    Inventors: Palle Schneider, Soren Christensen, Lone Dybdal, Claus Crone Fuglsang, Feng Xu, Elizabeth Golightly
  • Publication number: 20030119164
    Abstract: The inventors have isolated lysophospholipases from Aspergillus (A. niger and A. oryzae) having molecular masses of about 68 kDa and amino acid sequences of 600-604 amino acid residues. The novel lysophospholipases have only a limited homology to known amino acid sequences. The inventors also isolated genes encoding the novel enzymes and cloned them into E. coli strains.
    Type: Application
    Filed: December 4, 2002
    Publication date: June 26, 2003
    Applicant: Novozymes A/S
    Inventors: Hiroaki Udagawa, Torben Peter Frandsen, Tom Anton Busk Nielsen, Markus Sakari Kauppinen, Soren Christensen
  • Patent number: 6514739
    Abstract: The inventors have isolated lysophospholipases from Aspergillus (A. niger and A. oryzae) having molecular masses of about 68 kDa and amino acid sequences of 600-604 amino acid residues. The novel lysophospholipases have only a limited homology to known amino acid sequences. The inventors also isolated genes encoding the novel enzymes and cloned them into E. coli strains.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: February 4, 2003
    Inventors: Hiroaki Udagawa, Torben Peter Frandsen, Tom Anton Busk Nielsen, Markus Sakari Kauppinen, Søren Christensen
  • Patent number: 6188758
    Abstract: A method and an apparatus manually route incoming calls in a network in which an individual subscriber may be reached by the same telephone number on a number of different terminals, depending on, e.g., the type of incoming call and the time of day. An incoming call is automatically directed to one telephone, from which the subscriber may select to direct the call, e.g., to a fax machine, or an answering service. The terminals in question may be specified by the subscriber and identified by short numbers. An SSP and an SCP may be adapted to perform the service.
    Type: Grant
    Filed: September 1, 1998
    Date of Patent: February 13, 2001
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Sören Christensen, Paul Fjuk, Sören Wallinder
  • Patent number: 6146865
    Abstract: The present invention relates to isolated nucleic acid sequences encoding polypeptides having pyranose oxidase activity. The invention also relates to nucleic acid constructs, vectors and host cells containing the nucleic acid sequences as well as recombinant methods for producing the polypeptides.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: November 14, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Soren Christensen, Soren Flensted Lassen, Palle Schneider
  • Patent number: 5257363
    Abstract: A method and system in which a programmed digital computer serving as a graphical "engine" is employed to construct an executable model for a complex system using a hierarchy of so called "Colored" Petri nets (CPN's or CP-nets). The operation of the complex system is specified in terms of a graphical net structure and formal net inscriptions, such as arc expressions and guards, which ensure development of a program, or executable model, and associated data structures, properly defining the system. Sophisticated syntax checks and other tools are provided for ensuring that the model so constructed conforms to a set of rules which guarantee valid system behavior.
    Type: Grant
    Filed: April 9, 1990
    Date of Patent: October 26, 1993
    Assignee: Meta Software Corporation
    Inventors: Robert M. Shapiro, Jawahar Malhotra, Kurt Jensen, Soren Christensen, Peter Huber